KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 2,615.00
0.00 (0.00%)
At close: Nov 6, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 50.78 billion as of November 5, 2026. It is the 32,003rd most valuable company in the world and the 1,762nd biggest in South Korea. Its market cap has decreased by 47.28% in one year.
Market Cap
50.78B
Enterprise Value
36.09B
Revenue
75.41B
Global Rank
Country Rank
#1,762 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 50.78B, a decrease of -89.70%. That is a compound annual growth rate of -31.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 50.78B | -54.36% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABION | 60.91B |
| IMGT Co.,Ltd. | 57.82B |
| PanGen Biotech | 55.41B |
| TegoScience | 53.72B |
| Psomagen | 51.36B |
| NovMetaPharma | 50.72B |
| Epibiotech | 48.21B |
| QuadMedicine | 47.71B |